Clinical advances in mastocytosis

No abstract is available for this paper.

• Publication year

  1995

• Venue

  International journal of clinical & laboratory research (Print)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02592695PMID 8788545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phototherapy of urticaria pigmentosa: Clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes

  2004cited by this paper
• Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.

  1995cited by this paper
• Human mast cells produce IL-8.

  1993cited by this paper
• The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.

  1993cited by this paper
• Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.

  1993cited by this paper
• Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.

  1993cited by this paper
• Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.

  1992cited by this paper
• Les mastocytoses systémiques

  1992cited by this paper
• c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.

  1992cited by this paper
• [Bone involvement with osteolytic predominance in systemic mastocytosis. A clinical case].

  1992cited by this paper
• Interleukin 4 is localized to and released by human mast cells

  1992cited by this paper
• The rat c-kit ligand, stem cell factor, induces c-kit receptor- dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function

  1992cited by this paper
• [Systemic mastocytosis].

  1992cited by this paper
• Response to interferon alfa-2b in a patient with systemic mastocytosis.

  1992cited by this paper
• Characterization of the anti-inflammatory effect of FK-506 on human mast cells.

  1991cited by this paper
• Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains.

  1991cited by this paper
• Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital.

  1991cited by this paper
• Classification and diagnosis of mastocytosis: current status.

  1991influential reference
• The treatment of mastocytosis: an overview.

  1991cited by this paper
• Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.

  1991cited by this paper
• General anaesthetics induce only histamine release selectively from human mast cells.

  1991cited by this paper
• The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype

  1991cited by this paper
• Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor.

  1991cited by this paper
• Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell.

  1990cited by this paper
• Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

  1990cited by this paper
• Anaesthetic management of systemic mastocytosis.

  1990cited by this paper
• Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes

  1990influential reference
• Cromolyn sodium in the management of systemic mastocytosis.

  1990cited by this paper
• Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.

  1990cited by this paper
• Beta-adrenoceptor metabolism in wild-type, Gs, and protein kinase A-variant S49 cells.

  1990cited by this paper
• Impaired gastric acid secretion in mast cell-deficient mice.

  1990cited by this paper
• Analysis of plasma histamine levels in patients with mast cell disorders.

  1989cited by this paper
• Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.

  1989cited by this paper
• Recent advances in the cellular and molecular biology of mast cells.

  1989cited by this paper
• The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis.

  1989cited by this paper
• A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis.

  1989cited by this paper
• The metabolism and immunology of bone.

  1989cited by this paper
• Development of human mast cells in vitro.

  1989cited by this paper
• Pathology of the lymph node and spleen in systemic mast cell disease.

  1988cited by this paper
• Evaluation of a radioimmunoassay for histamine measurement in biologic fluids.

  1988cited by this paper
• Gastrointestinal dysfunction in systemic mastocytosis. A prospective study.

  1988cited by this paper
• Bone marrow findings in adult patients with urticaria pigmentosa.

  1988cited by this paper
• Systemic Mast Cell Disease: ANALYSIS OF 58 CASES AND LITERATURE REVIEW

  1988cited by this paper
• Pathology of the lymph node and spleen in systemic mast cell disease.

  1988cited by this paper
• Significance of systemic mast cell disease with associated hematologic disorders

  1988cited by this paper
• Mastocytosis with malabsorption, myelofibrosis, and massive ascites.

  1987cited by this paper
• Plasma histamine concentrations in evaluation of pediatric mastocytosis.

  1987cited by this paper
• Mastocytosis in Childhood

  1987cited by this paper
• Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption.

  1987cited by this paper
• Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

  1987influential reference
• Cutaneous mastocytosis in children: anaesthetic considerations

  1987cited by this paper
• The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.

  1986cited by this paper
• Dermal mast cells in mastocytosis: fixation, distribution and quantitation.

  1986cited by this paper
• Histamine food poisoning: toxicology and clinical aspects.

  1986cited by this paper
• Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.

  1985cited by this paper
• Bone marrow findings in systemic mastocytosis.

  1985cited by this paper
• Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial.

  1985cited by this paper
• Adult-onset urticaria pigmentosa and systemic mast cell disease.

  1985cited by this paper
• Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis.

  1985cited by this paper
• Congenital bullous urticaria pigmentosa. Treatment with concomitant use of H1- and H2-receptor antagonists.

  1985cited by this paper
• Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.

  1985cited by this paper
• Treatment of urticaria pigmentosa with corticosteroids.

  1985cited by this paper
• Bullous Mastocytosis: Diffuse Cutaneous Mastocytosis with Extensive Blisters Mimicking Scalded Skin Syndrome or Erythema Multiforme

  1984cited by this paper
• Systemic mastocytosis in a 5‐year‐old child: successful treatment with disodium cromoglycate

  1984cited by this paper
• Patterns of skeletal scintigraphy and their relationship to plasma and urinary histamine levels in systemic mastocytosis.

  1984cited by this paper
• Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations.

  1984cited by this paper
• Treatment of bullous mastocytosis with disodium cromoglycate.

  1983cited by this paper
• Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa

  1983cited by this paper
• Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites.

  1983cited by this paper
• Intervention with epinephrine in hypotension associated with mastocytosis.

  1983cited by this paper
• A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa.

  1983cited by this paper
• Anaphylaxis after Hymenoptera stings in three patients with urticaria pigmentosa.

  1983cited by this paper
• Persistent spontaneous heparinaemia in systemic mastocytosis.

  1982cited by this paper
• Mastocytosis and the mast cell.

  1982cited by this paper
• Systemic mast cell disease: A clinical and hematopathologic study of 26 cases

  1982influential reference
• Heparin liberation in urticaria pigmentosa.

  1982cited by this paper
• Bone marrow mast cell content in preleukemic syndrome.

  1982cited by this paper
• Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate

  1981cited by this paper
• Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders.

  1981cited by this paper
• Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa.

  1981influential reference
• Systemic mastocytosis associated with generalized osteopenia. Histopathological characterization of the skeletal lesion using undecalcified bone from two patients.

  1981cited by this paper
• Bullous urticaria pigmentosa (cutaneous mastocytosis) and sodium cromoglycate therapy.

  1981cited by this paper
• Eosinophilia in systemic mastocytosis.

  1980cited by this paper
• Malabsorption and gastric hyperacidity in systemic mastocytosis. Results of cimetidine therapy.

  1980cited by this paper
• Increased production of prostaglandin D2 in patients with systemic mastocytosis.

  1980cited by this paper
• Heparin activity in systemic mastocytosis.

  1979cited by this paper
• Oral disodium cromoglycate in the treatment of systemic mastocytosis.

  1979cited by this paper
• Pseudoxanthomatous mastocytosis

  1975cited by this paper
• An automated continuous-flow system for the extraction and fluorometric analysis of histamine.

  1974cited by this paper
• Mast cell infiltrates of the skin and the mastocytosis syndrome.

  1973cited by this paper
• Urticaria pigmentosa and acute lymphoblastic leukemia.

  1973cited by this paper
• Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine.

  1972cited by this paper
• Hyperchlorhydria and hyperhistaminemia in a patient with systemic mastocytosis.

  1970cited by this paper
• Bullous mastocytosis.

  1970cited by this paper
• Mastocytosis with osseous lesions resembling metastatic malignant lesions in bone.

  1968cited by this paper
• Urinary sulphatase activity in mastocytosis.

  1967cited by this paper
• Malignant Carcinoid Syndrome Associated with Noncarcinoid Tumors

  1965cited by this paper
• The mast cells

  1965cited by this paper
• Urticaria pigmentosa and systemic mastocytosis.

  1965cited by this paper
• INHIBITION OF THE ACTIVITIES OF GLUTAMIC, MALIC AND LACTIC DEHYDROGENASES BY GLUCOCORTICOIDS IN NORMAL AND PSORIATIC EPIDERMIS.

  1964cited by this paper

• Comité de Estándares de la Sociedad Española de Neonatología

  2016cites this paper
• Systemic mastocytosis: a rare cause of single vertebral body uptake on bone scan.

  2015cites this paper
• Chapter 15 – Miscellaneous Bone Diseases

  2014cites this paper
• Chapitre 20 – Néoplasies lymphoïdes et myéloïdes

  2013cites this paper
• Advanced imaging of skeletal manifestations of systemic mastocytosis

  2012influential citation
• Treatment of systemic mastocytosis.

  2006cites this paper
• Allergic eye disease associated with mastocytosis

  2003cites this paper
• Histologische Charakteristika und Häufigkeit der sekundären Osteoporose bei systemischer Mastozytose Eine retrospektive Analyse an 158 Fällen

  2001cites this paper
• Mastocitosis multinodular globulosa

  2001cites this paper
• [Histological characteristics and prevalence of secondary osteoporosis in systemic mastocytosis. A retrospective analysis of 158 cases].

  2001cites this paper
• Treatment of systemic mast cell disorders.

  2000cites this paper
• Mastocytosis with skin manifestations: current status

  1999cites this paper
• SYSTEMIC MASTOCYTOSIS AND OTHER MAST CELL NEOPLASMS

  1999cites this paper
• [Mastocytosis].

  1998cites this paper
• c-kit mutation and osteopetrosis-like osteopathy in a patient with systemic mast cell disease

  1998cites this paper
• In situ characterization of mast cells in the frog Rana esculenta

  1998cites this paper
• Multilineage involvement and erythropoietin-"independent" erythroid progenitor cells in a patient with systemic mastocytosis

  1998cites this paper
• [Urticaria pigmentosa and mastocytosis].

  1998cites this paper
• Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.

  1998cites this paper